Gordon EM - Search Results

1

Incorporation of tumor vasculature targeting motifs into moloney murine leukemia virus env escort proteins enhances retrovirus binding and transduction of human endothelial cells.

Liu L, Anderson WF, Beart RW, Gordon EM, Hall FL. Liu L, et al. Among authors: gordon em. J Virol. 2000 Jun;74(11):5320-8. doi: 10.1128/jvi.74.11.5320-5328.2000. J Virol. 2000. PMID: 10799609 Free PMC article.

2

Targeting retroviral vectors to vascular lesions by genetic engineering of the MoMLV gp70 envelope protein.

Hall FL, Gordon EM, Wu L, Zhu NL, Skotzko MJ, Starnes VA, Anderson WF. Hall FL, et al. Among authors: gordon em. Hum Gene Ther. 1997 Dec 10;8(18):2183-92. doi: 10.1089/hum.1997.8.18-2183. Hum Gene Ther. 1997. PMID: 9449372

3

Characterization of the proline-rich region of murine leukemia virus envelope protein.

Weimin Wu B, Cannon PM, Gordon EM, Hall FL, Anderson WF. Weimin Wu B, et al. Among authors: gordon em. J Virol. 1998 Jul;72(7):5383-91. doi: 10.1128/JVI.72.7.5383-5391.1998. J Virol. 1998. PMID: 9620992 Free PMC article.

4

Molecular engineering of matrix-targeted retroviral vectors incorporating a surveillance function inherent in von Willebrand factor.

Hall FL, Liu L, Zhu NL, Stapfer M, Anderson WF, Beart RW, Gordon EM. Hall FL, et al. Among authors: gordon em. Hum Gene Ther. 2000 May 1;11(7):983-93. doi: 10.1089/10430340050015293. Hum Gene Ther. 2000. PMID: 10811227

5

Inhibition of metastatic tumor growth in nude mice by portal vein infusions of matrix-targeted retroviral vectors bearing a cytocidal cyclin G1 construct.

Gordon EM, Liu PX, Chen ZH, Liu L, Whitley MD, Gee C, Groshen S, Hinton DR, Beart RW, Hall FL. Gordon EM, et al. Cancer Res. 2000 Jul 1;60(13):3343-7. Cancer Res. 2000. PMID: 10910035

6

Retroviral vectors bearing IgG-binding motifs for antibody-mediated targeting of vascular endothelial growth factor receptors.

Masood R, Gordon EM, Whitley MD, Wu BW, Cannon P, Evans L, Anderson WF, Gill P, Hall FL. Masood R, et al. Among authors: gordon em. Int J Mol Med. 2001 Oct;8(4):335-43. doi: 10.3892/ijmm.8.4.335. Int J Mol Med. 2001. PMID: 11562769

7

Gene therapy using retroviral vectors.

Gordon EM, Anderson WF. Gordon EM, et al. Curr Opin Biotechnol. 1994 Dec;5(6):611-6. doi: 10.1016/0958-1669(94)90083-3. Curr Opin Biotechnol. 1994. PMID: 7765744 Review.

8

Clinical protocol. Tumor site specific phase I evaluation of safety and efficacy of hepatic arterial infusion of a matrix-targeted retroviral vector bearing a dominant negative cyclin G1 construct as intervention for colorectal carcinoma metastatic to liver.

Lenz HJ, Anderson WF, Hall FL, Gordon EM. Lenz HJ, et al. Among authors: gordon em. Hum Gene Ther. 2002 Aug 10;13(12):1515-37. doi: 10.1089/10430340260185148. Hum Gene Ther. 2002. PMID: 12215272 No abstract available.

9

Downregulation of cyclin G1 expression by retrovirus-mediated antisense gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation.

Zhu NL, Wu L, Liu PX, Gordon EM, Anderson WF, Starnes VA, Hall FL. Zhu NL, et al. Among authors: gordon em. Circulation. 1997 Jul 15;96(2):628-35. doi: 10.1161/01.cir.96.2.628. Circulation. 1997. PMID: 9244236

10

Capture and expansion of bone marrow-derived mesenchymal progenitor cells with a transforming growth factor-beta1-von Willebrand's factor fusion protein for retrovirus-mediated delivery of coagulation factor IX.

Gordon EM, Skotzko M, Kundu RK, Han B, Andrades J, Nimni M, Anderson WF, Hall FL. Gordon EM, et al. Hum Gene Ther. 1997 Jul 20;8(11):1385-94. doi: 10.1089/hum.1997.8.11-1385. Hum Gene Ther. 1997. PMID: 9295133

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters